Schizophrenia Clinical Trial
Official title:
Past Pain Experience and Perception of Experimental Pain
Differences in pain perception between subjects with and without psychiatric illness may be
influenced by the individual experience, and not primarily by the pathology, although the
pathological frame may amplify it.The aim of this study is to establish if the
characteristics of experimental pain feeling are influenced by the past pain experience,
anxiety and emotion, independently from the diagnosis. The pain experience will be evaluated
by an inventory of the potentially painful situations that one can come across through the
life, to determine the following points : Number of painful events in the past, number of
painful points during the last 6 months, number of painful events lasting more than 6
months, sum of pain intensities (graduated with Visual Analogic Scale VAS from 0 to 10), sum
of gravity (evaluated from 0 to 5), the category of pain experience qualification (mostly
affective, mostly sensorial, or both).
Schizophrenic, depressed and control participants will be recruited, and their pain
experience throughout life will be put it in relation to experimental pain tests results
(pressure application, ischemia induction), anxiety and emotion (Hospital Anxiety and
Depression scale HAD), catastrophizing (Pain Catastrophizing Scale PCS), Heart Rate (HR)
variation, Blood Pressure (BP) variation.
The perception of moderated experimental pain (about 3 out of ten with visual analogue scale
VAS) in subjects with schizophrenia (Girard et coll., 2011), major depression (ED) (bipolar
or isolated/recurrent episode) (to be published) in comparison with controls without
psychiatric pathologies show that exploration of pain in situation like medical examination
to identify painful points should be done in the same conditions for persons with
psychiatric troubles and persons without mental disease. But the risk is that the expression
of pain, either in experimental conditions nor in the daily life, is not in relation with
the feeling or perception of pain. Numerous factors may interfere in the pain message
modulation, like the past pain experience, stress and anxiety, which are not or partially
explored in experimental studies. The individual experience of pain is constructed
throughout the whole life, from several influences (biological, psychological, and
sociocultural). The symptoms interfaces of the different psychiatric troubles seem to be
widely involved in the pain process, and its progressive construction. This study aims to
better understand the relationships between all those variables.
Procedures applied :
Anterior pain experience evaluation (questionnaire); Pain tests : 160 kPa pressure
application to determine corresponding pain with VAS), and ischemia induction to determine
the time necessary to obtain a pain equivalent to 3 out of 10; anxiety and emotional
evaluation (Hospital Anxiety and Depression scale), catastrophizing evaluation (Pain
Catastrophizing Scale), HR variation and BP variation (vegetative measures linked to
anxiety) collection of diagnosis, and therapeutic treatment
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |